Omega-3 Market

Omega-3 Market by Type (DHA, EPA, AND ALA), Application (Dietary Supplements, Functional Foods & Beverages, Pharmaceuticals, Infant Formula, and Pet Food & Feed), Source (Marine and Plant), and Region - Global Forecast to 2029

Report Code: FB 2759 Feb, 2024, by marketsandmarkets.com

[318 Pages Report] According to MarketsandMarkets, the omega-3 market is projected to reach USD 7.4 billion by 2029 from USD 3.9 billion by 2024, at a CAGR of 13.5% during the forecast period in terms of value.  Conventional fish oil sources are no longer the sole choice. Sustainable and plant-based substitutes such as algae, flaxseed, and chia seed oil are becoming increasingly popular, addressing dietary limitations and ethical considerations. Furthermore, novel formats like micro-emulsified supplements and fortified food items are enhancing convenience and attractiveness, appealing to a broader demographic. As individuals increasingly adopt proactive approaches to uphold well-being and stave off chronic ailments, Omega-3 supplements and fortified foods emerge as promising solutions, attracting those striving for good health and preemptive care.

Omega-3 Market

To know about the assumptions considered for the study, Request for Free Sample Report

Omega-3 Market Opportunities

To know about the assumptions considered for the study, download the pdf brochure

Market Dynamics

Driver : Innovative product technologies

Innovative technologies such as encapsulation and flavoring systems play a pivotal role as drivers for the Omega-3 market by masking the natural taste of plant-based Omega-3s, rendering them more palatable and appealing to a broader audience. This is crucial for boosting adoption rates and ensuring compliance with regular consumption. Additionally, the implementation of smart packaging and tracking systems facilitates the monitoring of Omega-3 product quality and potency throughout the supply chain, thereby safeguarding product integrity and offering consumers transparency and confidence. Moreover, advancements in technologies like microencapsulation and phospholipid delivery systems are enhancing the bioavailability of Omega-3s and mitigating unpleasant aftertastes commonly associated with traditional fish oil supplements. These innovations ultimately make Omega-3s more effective and enjoyable, driving market growth.

Restraint : Lower fish oil supply due to sustainability issues among fisheries

The constraint of lower fish oil supply due to sustainability issues among fisheries poses a significant challenge for the Omega-3 market. This limitation stems from the depletion of fish stocks caused by overfishing and unsustainable fishing practices, leading to reduced availability of fish oil, a primary source of Omega-3 fatty acids. As fisheries struggle to maintain sustainable practices, there is a decline in the quantity of fish oil extracted, consequently impacting the production of Omega-3 supplements and fortified foods. This scarcity in the supply chain not only hinders the ability of manufacturers to meet consumer demand but also raises concerns about the long-term viability of sourcing fish oil as a sustainable Omega-3 solution. As a result, the Omega-3 market faces constraints in maintaining adequate supply levels to satisfy market demand, potentially leading to increased prices and reduced accessibility for consumers.

Opportunity : Research for development of alternative sources to obtain omega-3

The research for the development of alternative sources to obtain Omega-3 presents a significant opportunity for the Omega-3 market. This initiative focuses on exploring and harnessing alternative sources such as algae, flaxseed, chia seeds, and marine microorganisms to extract Omega-3 fatty acids. These alternative sources offer several advantages, including sustainability, scalability, and reduced environmental impact compared to traditional fish oil extraction methods. Additionally, advancements in technology and biotechnology have enabled the production of Omega-3 supplements and fortified foods from these alternative sources, ensuring consistent quality and potency. By diversifying the sources of Omega-3 production, the market becomes less reliant on finite marine resources and mitigates the risks associated with overfishing and environmental degradation. Moreover, the availability of plant-based and sustainable Omega-3 options appeals to environmentally conscious consumers and those with dietary restrictions, expanding the consumer base and driving market growth. Therefore, the research for the development of alternative Omega-3 sources presents a promising opportunity to innovate and meet the growing demand for Omega-3 products in a sustainable and responsible manner.

Challenge: Instability of fish oils

The instability of fish oils represents a significant challenge for the Omega-3 market. Fish oils, which are a primary source of Omega-3 fatty acids, are susceptible to oxidation and rancidity due to their high levels of unsaturated fats. This instability can lead to a reduction in product quality, potency, and shelf life, negatively impacting consumer confidence and market acceptance. Additionally, the development of off-flavors and unpleasant odors in fish oil supplements further diminishes their appeal to consumers. Manufacturers face difficulties in maintaining the stability of fish oil-based Omega-3 products throughout the production, storage, and distribution processes. This challenge necessitates the implementation of stringent quality control measures, including the use of antioxidants, specialized packaging, and storage conditions, to minimize oxidation and preserve product integrity. However, despite these efforts, the instability of fish oils remains a persistent challenge for the Omega-3 market, requiring ongoing research and innovation to overcome.

OMEGA-3
Market Ecosystem

Key players within this market consist of reputable and financially robust omega-3 manufacturers. These entities boast extensive industry tenure, offering diversified product portfolios, cutting-edge technologies, and robust global sales and marketing networks. Prominent companies in this market BASF SE (Germany), Cargill, Incorporated. (US), dsm-firmenich (Netherlands), ADM (US), Kerry Group Plc (Ireland), Croda International Plc (UK), Orkla.  (Norway), Corbion (Netherlands), GC Rieber (Norway), Pelagia AS (Norway), KD Pharma Group SA (Switzerland), Cooke Aquaculture Inc. (Canada), AlgiSys Biosciences, Inc. (US), Golden Omega (Chile), AKER BIOMARINE (Norway), and Polaris (France).

Top Companies in Omega-3 Market

Plant source segment is expected to maintain consistent growth in omega-3 market during the forecast period.

Plant-powered Omega-3s are surging, fueled by ethically-conscious consumers seeking sustainable alternatives. Vegan, vegetarian, and allergy-friendly, these innovative options like algae oil and chia seed extracts boast potential unique health benefits and wider accessibility. Affordability and government initiatives promoting sustainable practices add further momentum. While ensuring potency and educating consumers remain key hurdles, the future of Omega-3 looks green, with this segment poised to shape a more responsible and inclusive market landscape.

The DHA segment is expected to hold the largest market share in the type segment of omega-3 market.

Research strongly supports the health benefits of DHA, from its crucial role in brain development to its potential for heart and eye health. Technology advancements have made DHA more accessible through refined extraction and processing methods. This increased accessibility has led to targeted applications, including pregnancy supplements and infant formula, promoting healthy development from early stages. DHA's influence extends to functional foods like dairy products and beverages, providing convenient ways to incorporate it into daily diets. Effective marketing strategies have solidified DHA's position by highlighting its unique benefits. While DHA leads the Omega-3 market, other players like EPA and ALA are also growing, offering diverse benefits and applications. This diversity ensures that the market can cater to various consumer needs, fostering a thriving landscape focused on individual well-being and holistic health.

North America to dominate the omega-3 market during the forecast period.

In North America, the demand for Omega-3 is increasing, particularly in dietary supplement applications, driven by the recognition of Omega-3's benefits health. Omega-3 fatty acids are among the most popular dietary supplements, known for their potential benefits for heart health, brain function, and overall well-being. The demand for omega-3 supplements in North America has been steadily increasing due to rising awareness about their health benefits and the inclusion of omega-3 in various health recommendations.

North American Omega-3 Market Size, and Share

Key Market Players

The key players in this market include BASF SE (Germany), Cargill, Incorporated. (US), dsm-firmenich (Netherlands), ADM (US), Kerry Group Plc (Ireland), Croda International Plc (UK), Orkla.  (Norway), Corbion (Netherlands), GC Rieber (Norway), Pelagia AS (Norway), KD Pharma Group SA (Switzerland), Cooke Aquaculture Inc. (Canada), AlgiSys Biosciences, Inc. (US), Golden Omega (Chile), AKER BIOMARINE (Norway), and Polaris (France). These market participants are emphasizing the expansion of their footprint via agreements and partnerships. They maintain a robust presence in North America, Asia Pacific, South America, RoW, and Europe, supported by manufacturing facilities and well-established distribution networks spanning across these regions.

Get online access to the report on the World's First Market Intelligence Cloud

  • Easy to Download Historical Data & Forecast Numbers
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
Request Sample

Scope of the Report

Report Metric

Details

Market size estimation

2024–2029

Base year considered

2023

Forecast period considered

2024–2029

Units considered

Value (USD)

Segments Covered

By Type, Source, Application, and Region

Regions covered

North America, Europe, South America, Asia Pacific, and RoW

Companies studied

  • BASF SE (Germany)
  • Cargill, Incorporated (US)
  • dsm-firmenich (Netherlands)
  • ADM (US)
  • Kerry Group Plc (Ireland)
  • Croda International Plc (UK)
  • Orkla (Norway)
  • Corbion (Netherlands)
  • Pelagia AS (US)
  • KD Pharma Group SA (Switzerland)
  • GC Rieber (Norway)
  • Cooke Aquaculture (Canada)
  • AlgiSys Biosciences, Inc. (US)
  • Golden Omega (Chile)
  • AKER BIOMARINE (Norway)
  • Polaris (France)
  • Nordic Naturals (US)
  • BTSA (Spain)
  • Farbest Brands (US)
  • KinOmega Biopharm Inc (China)
  • Pharma Marine AS (Norway)
  • Rimfrost AS (Norway)
  • Algarithm (Canada)
  • Solutex (Spain)
  • Cellana Inc (US)
  • Sinomega Biotech Engineering Co., Ltd. (China)
  • AlgaeCytes (UK)

This research report categorizes the omega-3 market based on type, source, application, and region.

Target Audience

  • Omega-3 traders, retailers, and distributors
  • Omega-3 manufacturers & suppliers
  • Related government authorities, commercial research & development (R&D) institutions.
  • Regulatory bodies, including government agencies and NGOs.
  • Commercial research & development (R&D) institutions and financial institutions.
  • Government and research organizations.
  • Venture capitalists and investors.
  • Technology providers to omega-3 and omega-3 companies.
  • Associations and industry bodies.   

Omega-3 Market:

By Type
  • Docosahexaenoic Acid (DHA)
  • Eicosapentaenoic Acid (EPA)
  • Alpha-Linolenic Acid (ALA)
By Source
  • Marine Source
  • Plant Source
By Application
  • Dietary Supplements
  • Functional Foods & Beverages
  • Pharmaceuticals
  • Infant Formula
  • Pet Food & Feed
By Region:
  • North America
  • Europe
  • Asia Pacific
  • South America
  • Rest of the World (RoW)

Recent Developments

  • In February 2023, GC Rieber VivoMega has introduced VivoMega Algae Oils, a line of high-concentration vegan Omega-3 sourced from microalgae and sourced from the ocean.
  • In March 2023, Pelagia has invested USD 40 million in the facility of Epax which is subsidiary of Pelagia in Aalesund. This facility will help the company to implement new technology known as EOP+Tech for EPA & DHA products.
  • In November 2021, AlgiSys BioSciences, Inc. Raised funding of USD 45 Million. This funding will fuel the company's initial commercial strategies, which are propelled by increasing global demand for EPA omega-3 fish oil substitutes.
  • In September 2023, in a collaborative effort, Aker BioMarine and Swisse introduced a groundbreaking product within Australia's Listed Assessed medicine category. Swisse Ultiboost High Strength Krill Oil, incorporating Aker BioMarine's Superba Boost Krill oil, received approval and is now listed on the Australia Register of Therapeutic Goods (ARTG) under AUST L(A) 417392.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 39)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
    1.3 STUDY SCOPE 
           1.3.1 MARKET SEGMENTATION
           1.3.2 INCLUSIONS AND EXCLUSIONS
           1.3.3 REGIONAL SCOPE
    1.4 YEARS CONSIDERED 
    1.5 UNITS CONSIDERED 
           1.5.1 CURRENCY CONSIDERED
                    TABLE 1 USD EXCHANGE RATES CONSIDERED, 2018–2023
           1.5.2 VOLUME UNIT
    1.6 STAKEHOLDERS 
    1.7 SUMMARY OF CHANGES 
           1.7.1 RECESSION IMPACT
 
2 RESEARCH METHODOLOGY (Page No. - 45)
    2.1 RESEARCH DATA 
           FIGURE 1 OMEGA-3 MARKET: RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY DATA
                    2.1.2.1 Key industry insights
                    2.1.2.2 List of key participants in primary interviews
                    2.1.2.3 Breakdown of primary interviews
    2.2 MARKET SIZE ESTIMATION 
           2.2.1 BOTTOM-UP APPROACH
                    FIGURE 2 OMEGA-3 MARKET: DEMAND-SIDE CALCULATION
           2.2.2 TOP-DOWN APPROACH
                    2.2.2.1 Approach to estimate market size using top-down analysis
                               FIGURE 3 OMEGA-3 MARKET: SUPPLY-SIDE CALCULATION
                               FIGURE 4 OMEGA-3 MARKET: SUPPLY SIDE
    2.3 DATA TRIANGULATION 
           FIGURE 5 DATA TRIANGULATION
    2.4 RESEARCH ASSUMPTIONS 
    2.5 LIMITATIONS AND RISK ASSESSMENT 
    2.6 RECESSION IMPACT ANALYSIS 
           2.6.1 RECESSION MACROINDICATORS
                    FIGURE 6 INDICATORS OF RECESSION
                    FIGURE 7 GLOBAL INFLATION RATE, 2011–2022
                    FIGURE 8 GLOBAL GDP, 2011–2022 (USD TRILLION)
                    FIGURE 9 RECESSION INDICATORS AND THEIR IMPACT ON OMEGA-3 MARKET
                    FIGURE 10 OMEGA-3 MARKET: EARLIER FORECAST VS. RECESSION FORECAST
 
3 EXECUTIVE SUMMARY (Page No. - 58)
    TABLE 2 OMEGA-3 MARKET SNAPSHOT, 2024 VS. 2029 
    FIGURE 11 OMEGA-3 MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION) 
    FIGURE 12 OMEGA-3 MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION) 
    FIGURE 13 OMEGA-3 MARKET, BY SOURCE, 2024 VS. 2029 (USD MILLION) 
    FIGURE 14 OMEGA-3 MARKET: REGIONAL SHARE, 2023 
 
4 PREMIUM INSIGHTS (Page No. - 62)
    4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN OMEGA-3 MARKET 
           FIGURE 15 RISING CHRONIC DISEASES TO DRIVE MARKET GROWTH
    4.2 OMEGA-3 MARKET IN ASIA PACIFIC, BY TYPE AND KEY COUNTRIES 
           FIGURE 16 DOCOSAHEXAENOIC ACID SEGMENT AND CHINA ACCOUNTED FOR LARGEST MARKET SHARES OF ASIA PACIFIC MARKET IN 2023
    4.3 OMEGA-3 MARKET, BY APPLICATION 
           FIGURE 17 DIETARY SUPPLEMENT SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
    4.4 OMEGA-3 MARKET, BY TYPE 
           FIGURE 18 DOCOSAHEXAENOIC ACID SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE FROM 2024 TO 2029
    4.5 OMEGA-3 MARKET, BY SOURCE 
           FIGURE 19 MARINE SEGMENT TO CLAIM LARGER MARKET SHARE DURING FORECAST PERIOD
 
5 MARKET OVERVIEW (Page No. - 65)
    5.1 INTRODUCTION 
    5.2 MACROECONOMIC INDICATORS 
           5.2.1 PREVENTIVE HEALTHCARE EXPENDITURE
                    FIGURE 20 PREVENTIVE HEALTHCARE EXPENDITURE AS PERCENTAGE OF GDP,  BY COUNTRY, 2020
           5.2.2 GROWING GERIATRIC POPULATION
                    FIGURE 21 POPULATION AGED 65 AND ABOVE (% OF TOTAL POPULATION), 2012–2022
    5.3 MARKET DYNAMICS 
           FIGURE 22 MARKET DYNAMICS: OMEGA-3 MARKET
           5.3.1 DRIVERS
                    5.3.1.1 Growing consumer awareness regarding health benefits of omega-3
                               TABLE 3 HEALTH BENEFITS ASSOCIATED WITH OMEGA-3 CONSUMPTION
                    5.3.1.2 Increasing use of omega-3 fatty acids in food and feed products
                               5.3.1.2.1 Rising demand for mother & infant nutrition products
                               TABLE 4 INFANT FORMULA CONSTITUENTS OF KEY BRANDS (PER 100 GM)
                               5.3.1.2.2 Growth focus of food processing companies on fortification
                               5.3.1.2.3 Increasing applications in pet food and feed
                               FIGURE 23 RECOMMENDED EPA LEVELS IN DOG FOOD (MG)
                    5.3.1.3 Growing adoption of innovative production technologies
           5.3.2 RESTRAINTS
                    5.3.2.1 Lower fish oil supply due to sustainability issues among fisheries
                    5.3.2.2 Lack of clarity among consumers about daily recommended intake and health claims
                               TABLE 5 EPA AND DHA DAILY INTAKE GUIDELINES BY VARIOUS ORGANIZATIONS
           5.3.3 OPPORTUNITIES
                    5.3.3.1 Increasing research for development of alternative sources to obtain omega-3
                               TABLE 6 UPCOMING ALTERNATIVE SOURCES FOR OMEGA-3 FATTY ACIDS
                               5.3.3.1.1 Rising consumer demand for plant-based products
                                             5.3.3.1.1.1 Growing focus on microalgae-based omega-3 production
                               FIGURE 24 MICROALGAE PROCESSING FOR OMEGA-3
                                             5.3.3.1.1.2 Side-effects and allergies related to fish-based products
                    5.3.3.2 Favorable regulatory environment
                    5.3.3.3 Application of microencapsulation technology to regulate release of nutrients in fortified food & beverages
           5.3.4 CHALLENGES
                    5.3.4.1 High costs involved in R&D activities
                    5.3.4.2 Highly unstable fish oil prices
                    5.3.4.3 Instability of omega-3 oils
    5.4 INVESTMENT AND FUNDING SCENARIO 
           FIGURE 25 OMEGA-3 MARKET: INVESTOR DEALS AND FUNDING
 
6 INDUSTRY TRENDS (Page No. - 80)
    6.1 INTRODUCTION 
    6.2 VALUE CHAIN ANALYSIS 
           6.2.1 RESEARCH & PRODUCT DEVELOPMENT
           6.2.2 MANUFACTURING
           6.2.3 MARKETING & SALES
           6.2.4 DISTRIBUTION
           6.2.5 POST-SALES SERVICES
                    FIGURE 26 OMEGA-3 MARKET: VALUE CHAIN ANALYSIS
    6.3 TECHNOLOGY ANALYSIS 
           6.3.1 MOLECULAR DISTILLATION
           6.3.2 ALGAE FERMENTATION
    6.4 PATENT ANALYSIS 
           FIGURE 27 KEY PATENTS GRANTED IN OMEGA-3 MARKET, 2014–2024
           FIGURE 28 REGIONAL ANALYSIS OF PATENTS GRANTED IN OMEGA-3 MARKET,  2014–2024
           6.4.1 LIST OF MAJOR PATENTS PERTAINING TO OMEGA-3 MARKET  (2014–2023)
    6.5 ECOSYSTEM ANALYSIS 
           6.5.1 DEMAND SIDE
           6.5.2 SUPPLY SIDE
                    TABLE 7 ROLE OF PARTICIPANTS IN ECOSYSTEM
                    FIGURE 29 OMEGA-3 MARKET: ECOSYSTEM ANALYSIS
    6.6 TRADE ANALYSIS 
           6.6.1 EXPORT DATA
                    TABLE 8 EXPORT VALUE OF OMEGA-3, BY KEY COUNTRY, 2022 (USD MILLION)
           6.6.2 IMPORT DATA
                    TABLE 9 IMPORT VALUE OF OMEGA-3, BY KEY COUNTRY, 2022 (USD MILLION)
    6.7 PRICING ANALYSIS 
           6.7.1 AVERAGE SELLING PRICE TREND OF PRODUCTS OFFERED  BY KEY PLAYERS, BY SOURCE
                    TABLE 10 OMEGA-3 MARKET: AVERAGE SELLING PRICE (ASP) TREND OF PRODUCTS OFFERED  BY KEY PLAYERS, BY SOURCE, 2023 (USD/KG)
           6.7.2 AVERAGE SELLING PRICE TREND OF OMEGA-3, BY SOURCE
                    TABLE 11 OMEGA-3 MARKET: AVERAGE SELLING PRICE (ASP) TREND OF OMEGA-3,  BY SOURCE, 2019–2023 (USD/KG)
           6.7.3 AVERAGE SELLING PRICE TREND OF MARINE SOURCES, BY REGION
                    TABLE 12 OMEGA-3 MARKET: AVERAGE SELLING PRICE (ASP) TREND OF MARINE SOURCES,  BY REGION, 2019–2023 (USD/KG)
           6.7.4 AVERAGE SELLING PRICE TREND OF PLANT SOURCES, BY REGION
                    TABLE 13 OMEGA-3 MARKET: AVERAGE SELLING PRICE (ASP) TREND OF PLANT SOURCES,  BY REGION, 2019–2023 (USD/KG)
    6.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES 
           FIGURE 30 TRENDS INFLUENCING OMEGA-3 MARKET
    6.9 KEY CONFERENCES AND EVENTS, 2024 
           TABLE 14 OMEGA-3 MARKET: LIST OF CONFERENCES AND EVENTS, 2023–2024
    6.10 REGULATORY LANDSCAPE 
           6.10.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND  OTHER ORGANIZATIONS
                    TABLE 15 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 16 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 17 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND  OTHER ORGANIZATIONS
           6.10.2 REGULATORY LANDSCAPE
                    6.10.2.1 North America
                               6.10.2.1.1 US
                               6.10.2.1.2 Canada
                    6.10.2.2 Europe
                    6.10.2.3 Asia Pacific
                               6.10.2.3.1 China
                               6.10.2.3.2 Japan
                               6.10.2.3.3 India
                    6.10.2.4 South America
                               6.10.2.4.1 Brazil
                               6.10.2.4.2 Argentina
                               6.10.2.4.3 Chile
                    6.10.2.5 RoW
                               6.10.2.5.1 South Africa
                               6.10.2.5.2 UAE
    6.11 CASE STUDY ANALYSIS 
           6.11.1 VERAMARIS ASSISTED BLAIR IN PRODUCING OMEGA-3 FATTY ACIDS FROM NATURAL MARINE ALGAE
           6.11.2 MIALGAE INTRODUCED SUSTAINABLE OMEGA-3 PRODUCTION WITH INNOVATIVE BIOTECHNOLOGY
           6.11.3 OMEGA-3 SUPPLEMENTS HELPED REDUCE SEIZURE FREQUENCY IN GREAT DANE SUFFERING FROM REFRACTORY CANINE EPILEPSY
    6.12 PORTER'S FIVE FORCES ANALYSIS 
                    TABLE 18 PORTER'S FIVE FORCES ANALYSIS
           6.12.1 INTENSITY OF COMPETITIVE RIVALRY
           6.12.2 BARGAINING POWER OF SUPPLIERS
           6.12.3 BARGAINING POWER OF BUYERS
           6.12.4 THREAT OF SUBSTITUTES
           6.12.5 THREAT OF NEW ENTRANTS
    6.13 KEY STAKEHOLDERS & BUYING CRITERIA 
           6.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
                    FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY SOURCE
                    TABLE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY SOURCE (%)
           6.13.2 BUYING CRITERIA
                    FIGURE 32 BUYING CRITERIA
                    TABLE 20 KEY BUYING CRITERIA FOR SOURCE SEGMENT
 
7 OMEGA-3 MARKET, BY TYPE (Page No. - 103)
    7.1 INTRODUCTION 
                    FIGURE 33 DOCOSAHEXAENOIC ACID SEGMENT TO DISPLAY HIGHEST CAGR DURING FORECAST PERIOD
                    TABLE 21 OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
                    TABLE 22 OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
    7.2 DOCOSAHEXAENOIC ACID 
           7.2.1 LOWERED RISK OF ALZHEIMER'S DISEASE TO DRIVE MARKET GROWTH
                    TABLE 23 FOOD SOURCES FOR DHA (GRAMS PER SERVING)
                    TABLE 24 DOCOSAHEXAENOIC ACID: OMEGA-3 MARKET, BY REGION, 2019–2023 (USD MILLION)
                    TABLE 25 DOCOSAHEXAENOIC ACID: OMEGA-3 MARKET, BY REGION, 2024–2029 (USD MILLION)
    7.3 EICOSAPENTAENOIC ACID 
           7.3.1 REDUCED SUSCEPTIBILITY TO CARDIOVASCULAR DISEASES TO BOOST DEMAND
                    TABLE 26 FOOD SOURCES FOR EPA (GRAMS PER SERVING)
                    TABLE 27 EICOSAPENTAENOIC ACID: OMEGA-3 MARKET, BY REGION, 2019–2023 (USD MILLION)
                    TABLE 28 EICOSAPENTAENOIC ACID: OMEGA-3 MARKET, BY REGION, 2024–2029 (USD MILLION)
    7.4 ALPHA-LINOLENIC ACID 
           7.4.1 GROWING POPULARITY AMONG VEGETARIANS AND VEGANS TO BOOST DEMAND
                    TABLE 29 FOOD SOURCES FOR ALA (GRAMS PER SERVING)
                    TABLE 30 ALPHA-LINOLENIC ACID: OMEGA-3 MARKET, BY REGION, 2019–2023 (USD MILLION)
                    TABLE 31 ALPHA-LINOLENIC ACID: OMEGA-3 MARKET, BY REGION, 2024–2029 (USD MILLION)
 
8 OMEGA-3 MARKET, BY SOURCE (Page No. - 110)
    8.1 INTRODUCTION 
           FIGURE 34 OMEGA-3 MARKET, BY SOURCE, 2024 VS. 2029 (USD MILLION)
           TABLE 32 OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
           TABLE 33 OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
           TABLE 34 OMEGA-3 MARKET, BY SOURCE, 2019–2023 (KT)
           TABLE 35 OMEGA-3 MARKET, BY SOURCE, 2024–2029 (KT)
    8.2 MARINE 
           8.2.1 SURGING DEMAND AMONG PREGNANT WOMEN FOR HEALTHY FETAL DEVELOPMENT TO DRIVE MARKET
                    TABLE 36 MARINE-BASED FOOD SOURCES CONTAINING OMEGA-3 ACIDS
                    TABLE 37 MARINE: OMEGA-3 MARKET, BY REGION, 2019–2023 (USD MILLION)
                    TABLE 38 MARINE: OMEGA-3 MARKET, BY REGION, 2024–2029 (USD MILLION)
                    TABLE 39 MARINE: OMEGA-3 MARKET, BY REGION, 2019–2023 (KT)
                    TABLE 40 MARINE: OMEGA-3 MARKET, BY REGION, 2024–2029 (KT)
                    TABLE 41 MARINE: OMEGA-3 MARKET, BY SOURCE TYPE, 2019–2023 (USD MILLION)
                    TABLE 42 MARINE: OMEGA-3 MARKET, BY SOURCE TYPE, 2024–2029 (USD MILLION)
    8.3 PLANT 
           8.3.1 GROWING USE OF FLAX SEEDS TO PREVENT CANCER TO BOOST DEMAND
                    TABLE 43 PLANT: OMEGA-3 MARKET, BY REGION, 2019–2023 (USD MILLION)
                    TABLE 44 PLANT: OMEGA-3 MARKET, BY REGION, 2024–2029 (USD MILLION)
                    TABLE 45 PLANT: OMEGA-3 MARKET, BY REGION, 2019–2023 (KT)
                    TABLE 46 PLANT: OMEGA-3 MARKET, BY REGION, 2024–2029 (KT)
                    TABLE 47 PLANT: OMEGA-3 MARKET, BY SOURCE TYPE, 2019–2023 (USD MILLION)
                    TABLE 48 PLANT: OMEGA-3 MARKET, BY SOURCE TYPE, 2024–2029 (USD MILLION)
 
9 OMEGA-3 MARKET, BY APPLICATION (Page No. - 119)
    9.1 INTRODUCTION 
           FIGURE 35 OMEGA-3 MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
           TABLE 49 OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
           TABLE 50 OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
    9.2 DIETARY SUPPLEMENT 
           9.2.1 GROWING IMPORTANCE OF BALANCED AND NUTRITIOUS DIET TO DRIVE MARKET
                    TABLE 51 DIETARY SUPPLEMENT: OMEGA-3 MARKET, BY REGION, 2019–2023 (USD MILLION)
                    TABLE 52 DIETARY SUPPLEMENT: OMEGA-3 MARKET, BY REGION, 2024–2029 (USD MILLION)
    9.3 FUNCTIONAL FOOD & BEVERAGE 
           9.3.1 ABILITY TO BOOST CARDIOVASCULAR HEALTH TO DRIVE DEMAND
                    TABLE 53 FUNCTIONAL FOOD & BEVERAGE: OMEGA-3 MARKET, BY REGION,  2019–2023 (USD MILLION)
                    TABLE 54 FUNCTIONAL FOOD & BEVERAGE: OMEGA-3 MARKET, BY REGION,  2024–2029 (USD MILLION)
    9.4 PHARMACEUTICAL 
           9.4.1 GROWING APPLICATION TO LOWER ELEVATED TRIGLYCERIDE LEVELS TO DRIVE MARKET
                    TABLE 55 PHARMACEUTICAL: OMEGA-3 MARKET, BY REGION, 2019–2023 (USD MILLION)
                    TABLE 56 PHARMACEUTICAL: OMEGA-3 MARKET, BY REGION, 2024–2029 (USD MILLION)
    9.5 INFANT FORMULA 
           9.5.1 RISING CONSUMPTION OMEGA-3 DHA DURING PREGNANCY TO BOOST DEMAND
                    TABLE 57 INFANT FORMULA: OMEGA-3 MARKET, BY REGION, 2019–2023 (USD MILLION)
                    TABLE 58 INFANT FORMULA: OMEGA-3 MARKET, BY REGION, 2024–2029 (USD MILLION)
    9.6 PET FOOD AND FEED 
           9.6.1 GREATER EMPHASIS ON BUILDING STRONG IMMUNITY IN PETS TO DRIVE MARKET
                    TABLE 59 PET FOOD AND FEED: OMEGA-3 MARKET, BY REGION, 2019–2023 (USD MILLION)
                    TABLE 60 PET FOOD AND FEED: OMEGA-3 MARKET, BY REGION, 2024–2029 (USD MILLION)
 
10 OMEGA-3 MARKET, BY REGION (Page No. - 127)
     10.1 INTRODUCTION 
               FIGURE 36 INDIA TO RECORD FASTEST GROWTH IN GLOBAL OMEGA-3 MARKET
               TABLE 61 OMEGA-3 MARKET, BY REGION, 2019–2023 (USD MILLION)
               TABLE 62 OMEGA-3 MARKET, BY REGION, 2024–2029 (USD MILLION)
               TABLE 63 OMEGA-3 MARKET, BY REGION, 2019–2023 (KT)
               TABLE 64 OMEGA-3 MARKET, BY REGION, 2024–2029 (KT)
     10.2 NORTH AMERICA 
               FIGURE 37 NORTH AMERICA: REGIONAL SNAPSHOT
             10.2.1 NORTH AMERICA: RECESSION IMPACT
                       FIGURE 38 OMEGA-3 MARKET IN NORTH AMERICA: RECESSION IMPACT ANALYSIS
                       TABLE 65 NORTH AMERICA: OMEGA-3 MARKET, BY COUNTRY, 2019–2023 (USD MILLION)
                       TABLE 66 NORTH AMERICA: OMEGA-3 MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
                       TABLE 67 NORTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
                       TABLE 68 NORTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
                       TABLE 69 NORTH AMERICA: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
                       TABLE 70 NORTH AMERICA: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
                       TABLE 71 NORTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
                       TABLE 72 NORTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
                       TABLE 73 NORTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (KT)
                       TABLE 74 NORTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (KT)
             10.2.2 US
                       10.2.2.1 Growing demand for plant-based omega-3 dietary supplements to drive market
                                   TABLE 75 US: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
                                   TABLE 76 US: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
                                   TABLE 77 US: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
                                   TABLE 78 US: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
                                   TABLE 79 US: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
                                   TABLE 80 US: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
                                   TABLE 81 US: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
             10.2.3 CANADA
                       10.2.3.1 Increased application in functional food & beverages to  boost demand
                                   TABLE 82 CANADA: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
                                   TABLE 83 CANADA: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
                                   TABLE 84 CANADA: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
                                   TABLE 85 CANADA: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
                                   TABLE 86 CANADA: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
                                   TABLE 87 CANADA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
                                   TABLE 88 CANADA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
             10.2.4 MEXICO
                       10.2.4.1 Growing focus on preventing heart diseases to drive market
                                   TABLE 89 MEXICO: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
                                   TABLE 90 MEXICO: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
                                   TABLE 91 MEXICO: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
                                   TABLE 92 MEXICO: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
                                   TABLE 93 MEXICO: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
                                   TABLE 94 MEXICO: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
     10.3 EUROPE 
             10.3.1 EUROPE: RECESSION IMPACT
                       FIGURE 39 OMEGA-3 MARKET IN EUROPE: RECESSION IMPACT ANALYSIS
                       TABLE 95 EUROPE: OMEGA-3 MARKET, BY COUNTRY, 2019–2023 (USD MILLION)
                       TABLE 96 EUROPE: OMEGA-3 MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
                       TABLE 97 EUROPE: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
                       TABLE 98 EUROPE: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
                       TABLE 99 EUROPE: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
                       TABLE 100 EUROPE: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
                       TABLE 101 EUROPE: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
                       TABLE 102 EUROPE: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
                       TABLE 103 EUROPE: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (KT)
                       TABLE 104 EUROPE: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (KT)
             10.3.2 GERMANY
                       10.3.2.1 Less fish consumption to boost demand for omega-3-based supplements
                                   TABLE 105 GERMANY: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
                                   TABLE 106 GERMANY: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
                                   TABLE 107 GERMANY: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
                                   TABLE 108 GERMANY: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
                                   TABLE 109 GERMANY: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
                                   TABLE 110 GERMANY: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
                                   TABLE 111 GERMANY: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
             10.3.3 UK
                       10.3.3.1 Ability to boost brain function and reduce inflammation to drive market
                                   TABLE 112 UK: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
                                   TABLE 113 UK: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
                                   TABLE 114 UK: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
                                   TABLE 115 UK: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
                                   TABLE 116 UK: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
                                   TABLE 117 UK: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
                                   TABLE 118 UK: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
             10.3.4 FRANCE
                       10.3.4.1 Ongoing innovations to boost quality and stability of omega-3-rich oils formulation to drive market
                                   TABLE 119 FRANCE: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
                                   TABLE 120 FRANCE: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
                                   TABLE 121 FRANCE: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
                                   TABLE 122 FRANCE: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
                                   TABLE 123 FRANCE: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
                                   TABLE 124 FRANCE: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
                                   TABLE 125 FRANCE: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
             10.3.5 NORWAY
                       10.3.5.1 Production of genetically modified canola to offer lucrative growth opportunities to players
                                   TABLE 126 NORWAY: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
                                   TABLE 127 NORWAY: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
                                   TABLE 128 NORWAY: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
                                   TABLE 129 NORWAY: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
                                   TABLE 130 NORWAY: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
                                   TABLE 131 NORWAY: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
             10.3.6 ITALY
                       10.3.6.1 High production of dietary supplements, functional food products, and beverages to boost demand
                                   TABLE 132 ITALY: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
                                   TABLE 133 ITALY: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
                                   TABLE 134 ITALY: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
                                   TABLE 135 ITALY: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
                                   TABLE 136 ITALY: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
                                   TABLE 137 ITALY: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
             10.3.7 SPAIN
                       10.3.7.1 Need for sufficient consumption of ALA, DHA and EPA from foods to accelerate demand
                                   TABLE 138 SPAIN: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
                                   TABLE 139 SPAIN: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
                                   TABLE 140 SPAIN: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
                                   TABLE 141 SPAIN: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
                                   TABLE 142 SPAIN: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
                                   TABLE 143 SPAIN: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
                                   TABLE 144 SPAIN: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
             10.3.8 NETHERLANDS
                       10.3.8.1 Growing incidences of depression, autism, and ADHD to drive market
                                   TABLE 145 NETHERLANDS: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
                                   TABLE 146 NETHERLANDS: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
                                   TABLE 147 NETHERLANDS: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
                                   TABLE 148 NETHERLANDS: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
                                   TABLE 149 NETHERLANDS: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
                                   TABLE 150 NETHERLANDS: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
                                   TABLE 151 NETHERLANDS: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
             10.3.9 REST OF EUROPE
                       TABLE 152 REST OF EUROPE: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
                       TABLE 153 REST OF EUROPE: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
                       TABLE 154 REST OF EUROPE: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
                       TABLE 155 REST OF EUROPE: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
                       TABLE 156 REST OF EUROPE: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
                       TABLE 157 REST OF EUROPE: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
                       TABLE 158 REST OF EUROPE: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
     10.4 ASIA PACIFIC 
               FIGURE 40 ASIA PACIFIC: REGIONAL SNAPSHOT
             10.4.1 ASIA PACIFIC: RECESSION IMPACT
                       FIGURE 41 OMEGA-3 MARKET IN ASIA PACIFIC: RECESSION IMPACT ANALYSIS
                       TABLE 159 ASIA PACIFIC: OMEGA-3 MARKET, BY COUNTRY, 2019–2023 (USD MILLION)
                       TABLE 160 ASIA PACIFIC: OMEGA-3 MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
                       TABLE 161 ASIA PACIFIC: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
                       TABLE 162 ASIA PACIFIC: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
                       TABLE 163 ASIA PACIFIC: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
                       TABLE 164 ASIA PACIFIC: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
                       TABLE 165 ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
                       TABLE 166 ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
                       TABLE 167 ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (KT)
                       TABLE 168 ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (KT)
             10.4.2 CHINA
                       10.4.2.1 Increasing focus on product innovations and diversifications to drive market
                                   TABLE 169 CHINA: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
                                   TABLE 170 CHINA: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
                                   TABLE 171 CHINA: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
                                   TABLE 172 CHINA: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
                                   TABLE 173 CHINA: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
                                   TABLE 174 CHINA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
                                   TABLE 175 CHINA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
             10.4.3 INDIA
                       10.4.3.1 Growing incidences of heart failure to drive market
                                   TABLE 176 INDIA: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
                                   TABLE 177 INDIA: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
                                   TABLE 178 INDIA: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
                                   TABLE 179 INDIA: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
                                   TABLE 180 INDIA: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
                                   TABLE 181 INDIA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
                                   TABLE 182 INDIA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
             10.4.4 JAPAN
                       10.4.4.1 Rising use of innovative formulation technology to create opportunities for manufacturers of omega-3 products
                                   TABLE 183 JAPAN: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
                                   TABLE 184 JAPAN: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
                                   TABLE 185 JAPAN: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
                                   TABLE 186 JAPAN: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
                                   TABLE 187 JAPAN: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
                                   TABLE 188 JAPAN: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
                                   TABLE 189 JAPAN: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
             10.4.5 AUSTRALIA
                       10.4.5.1 Government-led initiatives to increase awareness regarding omega-3 to drive market
                                   TABLE 190 AUSTRALIA: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
                                   TABLE 191 AUSTRALIA: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
                                   TABLE 192 AUSTRALIA: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
                                   TABLE 193 AUSTRALIA: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
                                   TABLE 194 AUSTRALIA: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
                                   TABLE 195 AUSTRALIA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
                                   TABLE 196 AUSTRALIA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
             10.4.6 NEW ZEALAND
                       10.4.6.1 Increasing consumer awareness and government regulations for omega-3 supplements to drive market growth
                                   TABLE 197 NEW ZEALAND: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
                                   TABLE 198 NEW ZEALAND: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
                                   TABLE 199 NEW ZEALAND: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
                                   TABLE 200 NEW ZEALAND: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
                                   TABLE 201 NEW ZEALAND: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
                                   TABLE 202 NEW ZEALAND: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
                                   TABLE 203 NEW ZEALAND: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
             10.4.7 REST OF ASIA PACIFIC
                       TABLE 204 REST OF ASIA PACIFIC: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
                       TABLE 205 REST OF ASIA PACIFIC: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
                       TABLE 206 REST OF ASIA PACIFIC: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
                       TABLE 207 REST OF ASIA PACIFIC: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
                       TABLE 208 REST OF ASIA PACIFIC: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
                       TABLE 209 REST OF ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
                       TABLE 210 REST OF ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
     10.5 SOUTH AMERICA 
             10.5.1 SOUTH AMERICA: RECESSION IMPACT
                       FIGURE 42 OMEGA-3 MARKET IN SOUTH AMERIC: RECESSION IMPACT ANALYSIS, 2023
                       TABLE 211 SOUTH AMERICA: OMEGA-3 MARKET, BY COUNTRY, 2019–2023 (USD MILLION)
                       TABLE 212 SOUTH AMERICA: OMEGA-3 MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
                       TABLE 213 SOUTH AMERICA: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
                       TABLE 214 SOUTH AMERICA: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
                       TABLE 215 SOUTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
                       TABLE 216 SOUTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
                       TABLE 217 SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
                       TABLE 218 SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
                       TABLE 219 SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (KT)
                       TABLE 220 SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (KT)
             10.5.2 BRAZIL
                       10.5.2.1 Rising demand for algal oils to drive market
                                   TABLE 221 BRAZIL: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
                                   TABLE 222 BRAZIL: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
                                   TABLE 223 BRAZIL: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
                                   TABLE 224 BRAZIL: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
                                   TABLE 225 BRAZIL: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
                                   TABLE 226 BRAZIL: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
             10.5.3 ARGENTINA
                       10.5.3.1 Commercialization of omega-3 products to fuel market growth
                                   TABLE 227 ARGENTINA: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
                                   TABLE 228 ARGENTINA: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
                                   TABLE 229 ARGENTINA: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
                                   TABLE 230 ARGENTINA: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
                                   TABLE 231 ARGENTINA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
                                   TABLE 232 ARGENTINA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
             10.5.4 REST OF SOUTH AMERICA
                       TABLE 233 REST OF SOUTH AMERICA: OMEGA-3 MARKET, BY APPLICATION,  2019–2023 (USD MILLION)
                       TABLE 234 REST OF SOUTH AMERICA: OMEGA-3 MARKET, BY APPLICATION,  2024–2029 (USD MILLION)
                       TABLE 235 REST OF SOUTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
                       TABLE 236 REST OF SOUTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
                       TABLE 237 REST OF SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
                       TABLE 238 REST OF SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
     10.6 ROW 
             10.6.1 ROW: RECESSION IMPACT
                       FIGURE 43 OMEGA-3 MARKET IN ROW: RECESSION IMPACT ANALYSIS
                       TABLE 239 ROW: OMEGA-3 MARKET, BY REGION, 2019–2023 (USD MILLION)
                       TABLE 240 ROW: OMEGA-3 MARKET, BY REGION, 2024–2029 (USD MILLION)
                       TABLE 241 ROW: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
                       TABLE 242 ROW: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
                       TABLE 243 ROW: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
                       TABLE 244 ROW: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
                       TABLE 245 ROW: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
                       TABLE 246 ROW: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
                       TABLE 247 ROW: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (KT)
                       TABLE 248 ROW: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (KT)
             10.6.2 AFRICA
                       TABLE 249 AFRICA: OMEGA-3 MARKET, BY COUNTRY, 2019–2023 (USD MILLION)
                       TABLE 250 AFRICA: OMEGA-3 MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
                       TABLE 251 AFRICA: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
                       TABLE 252 AFRICA: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
                       TABLE 253 AFRICA: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
                       TABLE 254 AFRICA: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
                       TABLE 255 AFRICA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
                       TABLE 256 AFRICA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
                       10.6.2.1 South Africa
                                   10.6.2.1.1 Prevalence of undernutrition among pregnant women and kids to drive demand
                                   TABLE 257 SOUTH AFRICA: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
                                   TABLE 258 SOUTH AFRICA: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
                                   TABLE 259 SOUTH AFRICA: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
                                   TABLE 260 SOUTH AFRICA: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
                                   TABLE 261 SOUTH AFRICA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
                                   TABLE 262 SOUTH AFRICA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
                       10.6.2.2 Egypt
                                   10.6.2.2.1 Improved pediatric health conditions to boost demand
                                   TABLE 263 EGYPT: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
                                   TABLE 264 EGYPT: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
                                   TABLE 265 EGYPT: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
                                   TABLE 266 EGYPT: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
                                   TABLE 267 EGYPT: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
                                   TABLE 268 EGYPT: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
                       10.6.2.3 Nigeria
                                   10.6.2.3.1 Rising prevalnce of artery diseases to boost demand
                                   TABLE 269 NIGERIA: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
                                   TABLE 270 NIGERIA: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
                                   TABLE 271 NIGERIA: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
                                   TABLE 272 NIGERIA: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
                                   TABLE 273 NIGERIA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
                                   TABLE 274 NIGERIA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
                       10.6.2.4 Rest of Africa
                                   TABLE 275 REST OF AFRICA: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
                                   TABLE 276 REST OF AFRICA: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
                                   TABLE 277 REST OF AFRICA: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
                                   TABLE 278 REST OF AFRICA: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
                                   TABLE 279 REST OF AFRICA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
                                   TABLE 280 REST OF AFRICA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
             10.6.3 MIDDLE EAST
                       TABLE 281 MIDDLE EAST: OMEGA-3 MARKET, BY COUNTRY, 2019–2023 (USD MILLION)
                       TABLE 282 MIDDLE EAST: OMEGA-3 MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
                       TABLE 283 MIDDLE EAST: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
                       TABLE 284 MIDDLE EAST: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
                       TABLE 285 MIDDLE EAST: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
                       TABLE 286 MIDDLE EAST: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
                       TABLE 287 MIDDLE EAST: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
                       TABLE 288 MIDDLE EAST: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
                       10.6.3.1 Saudi Arabia
                                   10.6.3.1.1 Ongoing innovations in omega-3 products to drive market
                                   TABLE 289 SAUDI ARABIA: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
                                   TABLE 290 SAUDI ARABIA: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
                                   TABLE 291 SAUDI ARABIA: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
                                   TABLE 292 SAUDI ARABIA: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
                                   TABLE 293 SAUDI ARABIA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
                                   TABLE 294 SAUDI ARABIA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
                       10.6.3.2 UAE
                                   10.6.3.2.1 Increasing awareness among consumers about health products to drive market
                                   TABLE 295 UAE: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
                                   TABLE 296 UAE: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
                                   TABLE 297 UAE: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
                                   TABLE 298 UAE: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
                                   TABLE 299 UAE: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
                                   TABLE 300 UAE: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
                       10.6.3.3 Qatar
                                   10.6.3.3.1 Growing research on algae to boost demand
                                   TABLE 301 QATAR: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
                                   TABLE 302 QATAR: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
                                   TABLE 303 QATAR: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
                                   TABLE 304 QATAR: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
                                   TABLE 305 QATAR: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
                                   TABLE 306 QATAR: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
                       10.6.3.4 Rest of Middle East
                                   TABLE 307 REST OF MIDDLE EAST: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
                                   TABLE 308 REST OF MIDDLE EAST: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
                                   TABLE 309 REST OF MIDDLE EAST: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
                                   TABLE 310 REST OF MIDDLE EAST: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
                                   TABLE 311 REST OF MIDDLE EAST: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
                                   TABLE 312 REST OF MIDDLE EAST: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
 
11 COMPETITIVE LANDSCAPE (Page No. - 219)
     11.1 OVERVIEW 
     11.2 MARKET SHARE ANALYSIS, 2022 
               TABLE 313 OMEGA-3 MARKET: DEGREE OF COMPETITION
     11.3 KEY PLAYERS STRATEGIES/RIGHT TO WIN, 2020–2024 
               TABLE 314 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN OMEGA-3 MARKET, 2020–2024
     11.4 BRAND/PRODUCT ANALYSIS 
               FIGURE 44 BRAND/PRODUCT ANALYSIS FOR KEY BRANDS
     11.5 SEGMENTAL REVENUE ANALYSIS, 2020–2022 
               FIGURE 45 THREE-YEAR SEGMENTAL REVENUE ANALYSIS OF KEY PLAYERS IN OMEGA-3 MARKET (USD BILLION)
     11.6 KEY PLAYERS’ ANNUAL REVENUE, 2022 VS.  REVENUE GROWTH, 2020–2022 
               FIGURE 46 ANNUAL REVENUE, 2022 (USD BILLION) VS. REVENUE GROWTH (%),  2020–2022
     11.7 EBIT/EBITDA ANALYSIS, 2022 
               FIGURE 47 EBIT/EBITDA (USD BILLION)
     11.8 GLOBAL SNAPSHOT OF KEY MARKET PARTICIPANTS, 2022 
               FIGURE 48 GLOBAL SNAPSHOT OF KEY PARTICIPANTS
     11.9 COMPANY VALUATION AND FINANCIAL METRICS 
               FIGURE 49 COMPANY VALUATION OF FEW MAJOR COMPANIES
               FIGURE 50 EV/EBITDA OF KEY COMPANIES
     11.10 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2022 
               11.10.1 STARS
               11.10.2 EMERGING LEADERS
               11.10.3 PERVASIVE PLAYERS
               11.10.4 PARTICIPANTS
                                   FIGURE 51 OMEGA-3 MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2022
               11.10.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
                                  11.10.5.1 Company footprint
                                                        TABLE 315 OVERALL COMPANY FOOTPRINT
                                  11.10.5.2 Type footprint
                                                        TABLE 316 OMEGA-3 MARKET: BY TYPE FOOTPRINT
                                  11.10.5.3 Source footprint
                                                        TABLE 317 OMEGA-3 MARKET: BY SOURCE FOOTPRINT
                                  11.10.5.4 Application footprint
                                                        TABLE 318 OMEGA-3 MARKET: BY APPLICATION FOOTPRINT
                                  11.10.5.5 Region footprint
                                                        TABLE 319 OMEGA-3 MARKET: BY REGION FOOTPRINT
     11.11 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2022 
               11.11.1 PROGRESSIVE COMPANIES
               11.11.2 RESPONSIVE COMPANIES
               11.11.3 DYNAMIC COMPANIES
               11.11.4 STARTING BLOCKS
                                   FIGURE 52 OMEGA-3 MARKET: COMPANY EVALUATION MATRIX (START-UPS/SMES), 2022
               11.11.5 COMPETITIVE BENCHMARKING, START-UPS/SMES, 2023
                                  11.11.5.1 List of key start-ups/SMEs
                                   TABLE 320 OMEGA-3 MARKET: LIST OF KEY START-UPS/SMES
                                  11.11.5.2 Competitive benchmarking of key start-ups/SMEs
                                   TABLE 321 OMEGA-3 MARKET: COMPETITIVE BENCHMARKING OF KEY START-UPS/SMES
     11.12 COMPETITIVE SCENARIO 
               11.12.1 PRODUCT LAUNCHES
                                   TABLE 322 OMEGA-3 MARKET: PRODUCT LAUNCHES, JANUARY 2020– FEBRUARY 2024
               11.12.2 DEALS
                                   TABLE 323 OMEGA-3 MARKET: DEALS, JANUARY 2020– FEBRUARY 2024
               11.12.3 EXPANSIONS
                                   TABLE 324 OMEGA-3 MARKET: EXPANSIONS, JANUARY 2020– FEBRUARY 2024
               11.12.4 OTHERS
                                   TABLE 325 OMEGA-3 MARKET: OTHERS, JANUARY 2020– FEBRUARY 2024
 
12 COMPANY PROFILES (Page No. - 246)
(Business Overview, Products/Solutions/Services Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
     12.1 KEY PLAYERS 
             12.1.1 BASF SE
                       TABLE 326 BASF SE: COMPANY OVERVIEW
                       FIGURE 53 BASF SE: COMPANY SNAPSHOT
                       TABLE 327 BASF SE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                       TABLE 328 BASF SE: PRODUCT LAUNCHES
             12.1.2 CARGILL, INCORPORATED
                       TABLE 329 CARGILL, INCORPORATED: COMPANY OVERVIEW
                       FIGURE 54 CARGILL, INCORPORATED.: COMPANY SNAPSHOT
                       TABLE 330 CARGILL, INCORPORATED: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                       TABLE 331 CARGILL, INCORPORATED: DEALS
             12.1.3 DSM-FIRMENICH
                       TABLE 332 DSM-FIRMENICH: COMPANY OVERVIEW
                       FIGURE 55 DSM-FIRMENICH: COMPANY SNAPSHOT
                       TABLE 333 DSM-FIRMENICH: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                       TABLE 334 DSM-FIRMENICH: PRODUCT LAUNCHES
             12.1.4 ADM
                       TABLE 335 ADM: COMPANY OVERVIEW
                       FIGURE 56 ADM: COMPANY SNAPSHOT
                       TABLE 336 ADM: PRODUCTS/SOLUTIONS/SERVICES OFFERED
             12.1.5 KERRY GROUP PLC
                       TABLE 337 KERRY GROUP PLC: BUSINESS OVERVIEW
                       FIGURE 57 KERRY GROUP PLC: COMPANY SNAPSHOT
                       TABLE 338 KERRY GROUP PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                       TABLE 339 KERRY GROUP PLC: DEALS
             12.1.6 AKER BIOMARINE
                       TABLE 340 AKER BIOMARINE: COMPANY OVERVIEW
                       FIGURE 58 AKER BIOMARINE: COMPANY SNAPSHOT
                       TABLE 341 AKER BIOMARINE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                       TABLE 342 AKER BIOMARINE: PRODUCT LAUNCHES
                       TABLE 343 AKER BIOMARINE: DEALS
             12.1.7 CRODA INTERNATIONAL PLC
                       TABLE 344 CRODA INTERNATIONAL PLC: COMPANY OVERVIEW
                       FIGURE 59 CRODA INTERNATIONAL PLC: COMPANY SNAPSHOT
                       TABLE 345 CRODA INTERNATIONAL PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
             12.1.8 ORKLA
                       TABLE 346 ORKLA: COMPANY OVERVIEW
                       FIGURE 60 ORKLA: COMPANY SNAPSHOT
                       TABLE 347 ORKLA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                       TABLE 348 ORKLA: DEALS
             12.1.9 CORBION
                       TABLE 349 CORBION: COMPANY OVERVIEW
                       FIGURE 61 CORBION: COMPANY SNAPSHOT
                       TABLE 350 CORBION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                       TABLE 351 CORBION: PRODUCT LAUNCHES
                       TABLE 352 CORBION: EXPANSIONS
             12.1.10 PELAGIA AS
                                   TABLE 353 PELAGIA AS: COMPANY OVERVIEW
                                   FIGURE 62 PELAGIA AS: COMPANY SNAPSHOT
                                   TABLE 354 PELAGIA AS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                                   TABLE 355 PELAGIA AS: DEALS
             12.1.11 KD PHARMA GROUP SA
                                   TABLE 356 KD PHARMA GROUP SA: COMPANY OVERVIEW
                                   TABLE 357 KD PHARMA GROUP SA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                                   TABLE 358 KD PHARMA GROUP SA: EXPANSIONS
             12.1.12 GC RIEBER
                                   TABLE 359 GC RIEBER: COMPANY OVERVIEW
                                   TABLE 360 GC RIEBER: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                                   TABLE 361 GC RIEBER: PRODUCT LAUNCHES
                                   TABLE 362 GC REIBER: DEALS
                                   TABLE 363 GC RIEBER: EXPANSIONS
             12.1.13 COOKE AQUACULTURE INC.
                                   TABLE 364 COOKE AQUACULTURE INC.: COMPANY OVERVIEW
                                   TABLE 365 COOKE AQUACULTURE INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                                   TABLE 366 COOKE AQUACULTURE INC.: DEALS
             12.1.14 ALGISYS BIOSCIENCES, INC.
                                   TABLE 367 ALGISYS BIOSCIENCES, INC.: COMPANY OVERVIEW
                                   TABLE 368 ALGISYS BIOSCIENCES, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                                   TABLE 369 ALGISYS BIOSCIENCES, INC.: OTHERS
             12.1.15 GOLDEN OMEGA
                                   TABLE 370 GOLDEN OMEGA: COMPANY OVERVIEW
                                   TABLE 371 GOLDEN OMEGA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                                   TABLE 372 GOLDEN OMEGA: DEALS
             12.1.16 POLARIS
                                   TABLE 373 POLARIS: COMPANY OVERVIEW
                                   TABLE 374 POLARIS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                                   TABLE 375 POLARIS: PRODUCT LAUNCHES
                                   TABLE 376 POLARIS: OTHERS
     12.2 OTHER PLAYERS 
             12.2.1 BTSA
                       TABLE 377 BTSA: COMPANY OVERVIEW
                       TABLE 378 BTSA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
             12.2.2 FARBEST BRANDS
                       TABLE 379 FARBEST BRANDS: COMPANY OVERVIEW
                       TABLE 380 FARBEST BRANDS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
             12.2.3 KINOMEGA BIOPHARM INC.
                       TABLE 381 KINOMEGA BIOPHARM INC.: COMPANY OVERVIEW
                       TABLE 382 KINOMEGA BIOPHARM INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
             12.2.4 PHARMA MARINE AS
                       TABLE 383 PHARMA MARINE AS: COMPANY OVERVIEW
                       TABLE 384 PHARMA MARINE AS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
             12.2.5 RIMFROST AS
                       TABLE 385 RIMFROST AS: COMPANY OVERVIEW
                       TABLE 386 RIMFROST AS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                       TABLE 387 RIMFROST AS: DEALS
             12.2.6 ALGARITHM
             12.2.7 SOLUTEX
             12.2.8 CELLANA INC.
             12.2.9 SINOMEGA BIOTECH ENGINEERING CO., LTD
             12.2.10 ALGAECYTES
 
13 ADJACENT AND RELATED MARKETS (Page No. - 306)
     13.1 INTRODUCTION 
               TABLE 388 ADJACENT MARKETS
     13.2 LIMITATIONS 
     13.3 COLLAGEN MARKET 
             13.3.1 MARKET DEFINITION
             13.3.2 MARKET OVERVIEW
                       TABLE 389 COLLAGEN MARKET, BY FORM, 2019–2022 (USD MILLION)
                       TABLE 390 COLLAGEN MARKET, BY FORM, 2023–2030 (USD MILLION)
     13.4 ALGAE PRODUCTS MARKET 
             13.4.1 MARKET DEFINITION
             13.4.2 MARKET OVERVIEW
                       TABLE 391 ALGAE PRODUCTS MARKET, BY SOURCE, 2018–2022 (USD MILLION)
                       TABLE 392 ALGAE PRODUCTS MARKET, BY SOURCE, 2023–2028 (USD MILLION)
 
14 APPENDIX (Page No. - 310)
     14.1 DISCUSSION GUIDE 
     14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’  SUBSCRIPTION PORTAL 
     14.3 CUSTOMIZATION OPTIONS 
     14.4 RELATED REPORTS 
     14.5 AUTHOR DETAILS 

The study involved four major activities in estimating the current size of the omega-3 market. Exhaustive secondary research was done to collect information on the market, peer, and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.

Secondary Research

This research study involved the extensive use of secondary sources—directories and databases such as Bloomberg Businessweek and Factiva—to identify and collect information useful for a technical, market-oriented, and commercial study of the omega-3 market.

In the secondary research process, various sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles from recognized authors, gold & silver standard websites, directories, and databases were referred to identify and collect information. This research study involved the extensive use of secondary sources—directories and databases such as Bloomberg Businessweek and Factiva—to identify and collect information useful for a technical, market-oriented, and commercial study of the omega-3 market.

Secondary research was mainly used to obtain key information about the industry’s supply chain, the total pool of key players, and market classification and segmentation as per the industry trends to the bottom-most level, regional markets, and key developments from both market- and technology-oriented perspectives.

Primary Research

Extensive primary research was conducted after obtaining information regarding the omega-3 market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand and supply sides across major countries of North America, Europe, Asia Pacific, the Middle East & Africa, and South America. Primary data was collected through questionnaires, emails, and telephonic interviews. The primary sources from the supply side included various industry experts, such as Chief X Officers (CXOs), Vice Presidents (VPs), Directors from business development, marketing, research, and development teams, and related key executives from distributors, and key opinion leaders. Primary interviews were conducted to gather insights such as market statistics, data on revenue collected from the products and services, market breakdowns, market size estimations, market forecasting, and data triangulation. Primary research also helped in understanding the various trends related to type, source, application, and region.

Omega-3  Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both the top-down and bottom-up approaches were used to estimate and validate the total size of the Omega-3 Market. These approaches were also used extensively to estimate the size of various dependent submarkets. The research methodology used to estimate the market size includes the following:

  • Key players were identified through extensive secondary research.
  • Primary and secondary research determined the industry’s value chain and market size.
  • All percentage share splits and breakdowns were determined using secondary sources and verified through primary sources.
  • All the possible parameters that affect the markets covered in this research study were accounted for, viewed in extensive detail, verified through primary research, and analyzed to obtain the final quantitative and qualitative data.
  • The following figure provides an illustrative representation of the complete market size estimation process implemented in this research study for an overall estimation of the omega-3 market in a consolidated format.

The following sections (bottom-up & top-down) depict the overall market size estimation process employed for the purpose of this study.

Global Omega-3 Market: Bottom-Up Approach

Omega-3  Market Bottom Up Approach

To know about the assumptions considered for the study, Request for Free Sample Report

Global Omega-3 Market: Top-Down Approach

Omega-3  Market Top Down Approach

Data Triangulation

After arriving at the overall market size from the estimation process explained above, the total market was split into several segments and subsegments. To estimate the overall omega-3 market and arrive at the exact statistics for all segments and subsegments, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from the demand and supply sides. The market size was also validated using both the top-down and bottom-up approaches.

Market Definition

According to the US Department of Health & Human Services, “Omega-3 fatty acids (omega-3s) have a carbon-carbon double bond located three carbons from the methyl end of the chain. Omega-3s, sometimes referred to as “n-3s,” are present in certain foods, such as flaxseed and fish, as well as dietary supplements, such as fish oil. Several different omega-3s exist, but the majority of scientific research focuses on three: alpha-linolenic acid (ALA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA). ALA contains 18 carbon atoms, whereas EPA and DHA are considered “long-chain” (LC) omega-3s because EPA contains 20 carbons, and DHA contains 22. ALA is found mainly in plant oils, such as flaxseed, soybean, and canola oils. DHA and EPA are found in fish and other seafood.”

Key Stakeholders

  • Manufacturers, dealers, and suppliers of omega-3
  • Government bodies
  • API, pharmaceutical products, and fortified food manufacturers
  • Fisheries and farms
  • Intermediate suppliers, such as retailers, wholesalers, and distributors
  • Raw material suppliers
  • Technology providers
  • Industry associations
  • Regulatory bodies and institutions
    • World Health Organization (WHO)
    • Code of Federal Regulations (CFR)
    • US Food and Drug Administration (FDA)
    • Codex Alimentarius Commission (CAC)
    • EUROPA
    • United States Department of Agriculture (USDA)
    • Food Processing Suppliers Association (FPSA)
  • Logistic providers & transporters
  • Research institutes and organizations
  • Consulting companies/consultants in the agricultural and animal farming technology sectors 

Report Objectives

Market Intelligence

 

  • Determining and projecting the size of the omega-3 market with respect to type, source, application, and region.
  • Identifying the attractive opportunities in the market by determining the largest and fastest-growing segments
  • Providing detailed information about the key factors influencing the market growth (drivers, restraints, opportunities, and industry-specific challenges)
  • Providing the regulatory framework and market entry process related to the omega-3 market.
  • Analyzing the micro markets with respect to individual growth trends, prospects, and their contribution to the total market.

Competitive Intelligence

  • Identifying and profiling the key players in the omega-3 market
  • Providing a comparative analysis of market leaders based on the following:
  • Product offerings
  • Business strategies
  • Strengths and weaknesses
  • Key financials
  • Understanding the competitive landscape and identifying the major growth strategies players across the country adopt.
  • Providing insights on key product innovations and investments in the omega-3 market.

Available Customizations:

With the given market data, MarketsandMarkets offers customizations according to company-specific scientific needs.

The following customization options are available for the report:

Product Analysis

  • Product Matrix, which gives a detailed comparison of the product portfolio of each company.

Geographic Analysis

With the given market data, MarketsandMarkets offers customizations according to company-specific scientific needs.

  • Further breakdown of the Rest of Europe into Belgium, Poland, Sweden, and other EU & non-EU countries
  • Further breakdown of the Rest of Asia Pacific into Taiwan, South Korea, Indonesia, Malaysia, Thailand, the Philippines, Bangladesh, Singapore, and Vietnam.  
  • Further breakdown of the Rest of South America into Chile, Peru, Uruguay, Venezuela, Colombia, and other South American countries

Company Information

  • Detailed analyses and profiling of additional market players (up to five)
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization
Report Code
FB 2759
Published ON
Feb, 2024
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Omega-3 Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback